Johnson & Johnson lowers 2026 profit forecast
29/07/2026 22:36
Johnson & Johnson lowers 2026 profit forecast July 29 (Reuters) - Johnson & Johnson JNJ.N cut 2026 profit forecast on Wednesday, citing the combined financial impact of its newly completed acquisition of Firefly Bio and a strategic partnership with Sail Biomedicines.
The healthcare giant expects full-year adjusted earnings per share of $10.96 to $11.11, compared with its previous forecast of $11.60 to $11.75.
(Reporting by Padmanabhan Ananthan in Bengaluru; Editing by Shilpi Majumdar)
Recent news on Johnson & Johnson
See all newsEli Lilly hits record high as healthcare stocks rally
Kenvue loses bid for rehearing after Tylenol autism lawsuits revived (updated)
Brief: Johnson & Johnson Announces New Data For Tremfya
Kenvue loses bid for rehearing after Tylenol autism lawsuits revived
Health Rounds: Glucose monitoring devices for type 2 diabetes benefit even those not on insulin